A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

The goal of this clinical trial is to learn if drugs Dapagliflozin and Empagliflozin work to treat NAFLD in Type 2 diabetes patients. It will also learn about the safety of drugs dapagliflozin and empagliflozin. The main questions it aims to answer are: Do drug dapagliflozin and empagliflozin lower the NAFLD degree for participants? What medical problems do participants have when taking the drugs dapagliflozin and empagliflozin? Researchers will compare drug dapagliflozin to empagliflozin to see which of them more effective to treat NAFLD. Participants will: Take drug dapagliflozin or empaglifloin every day for 6 months Visit the clinic once every 2 weeks for checkups and tests Keep a diary of their symptoms and the number of times they use a rescue inhaler

NCT Number	NCT07363707
Lead Sponsor	Beni-Suef University
Conditions	NAFLD (Nonalcoholic Fatty Liver Disease)
Enrollment	108 participants
Start Date	2023-05-01
Primary Completion	2023-08-27 (estimated)
Study Completion	2024-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-03